| Nome do produto |
BUPRENORFINA B-D-GLUCURONIDA |
| Sinônimos |
(57-17-(Ciclopropilmetil)-4,5-epóxi-18,19-diidro-7-[(1S)-1-hidroxi-1,2,2,-trimetilpropil]-6-metoxi-6,14-etenomorfinan-3-ilo b-D-Glucuronida; buprenorfina-3-O-glucuronida; (5,7)-17-(ciclopropilmetil)-4,5-epóxi-18,19-diidro-7-[(1S)-1-hidroxi-1,2,2,-trimetilpropil]-6-metoxi-6,14-etenomorfinan-3-il-D-glucuronida; Buprenorfina -D-Glucuronida; ácido (5alfa,6beta,14beta,18R)-17-(ciclopropilmetil)-18-[(2S)-2-hidroxi-3,3-dimetilbutano-2-il]-6-metoxi-18,19-diidro-4,5-epóxi-6,14-etenomorfinan-2-il-beta-D-glicopiranosidurônico |
| Nome em inglês |
BUPRENORPHINE B-D-GLUCURONIDE;(57-17-(Cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-7-[(1S)-1-hydroxy-1,2,2,-trimethylpropyl]-6-methoxy-6,14-ethenomorphinan-3-yl b-D-Glucuronide; buprenorphine-3-O-glucuronide; (5,7)-17-(Cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-7-[(1S)-1-hydroxy-1,2,2,-trimethylpropyl]-6-methoxy-6,14-ethenomorphinan-3-yl -D-Glucuronide; Buprenorphine -D-Glucuronide; (5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-2-yl beta-D-glucopyranosiduronic acid |
| Fórmula molecular |
C35H49NO10 |
| Peso Molecular |
643.7643 |
| InChI |
InChI=1/C35H49NO10/c1-31(2,3)32(4,42)21-15-33-8-9-35(21,43-5)30-34(33)10-11-36(16-17-6-7-17)22(33)13-18-12-19(14-20(45-30)23(18)34)44-29-26(39)24(37)25(38)27(46-29)28(40)41/h12,14,17,21-22,24-27,29-30,37-39,42H,6-11,13,15-16H2,1-5H3,(H,40,41)/t21-,22-,24+,25+,26-,27+,29-,30-,32+,33-,34+,35-/m1/s1 |
| CAS Registry Number |
101224-22-0 |
| Estrutura Molecular |
|
| Densidade |
1.43g/cm3 |
| índice de refração |
1.657 |
| Símbolos de perigo |
|
| Códigos de risco |
|
| Descrição da Segurança |
|
|
PT
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
RU
SA
TR
